Bill Meagher's focus with The Deal is on small and microcap equity finance, SEC regulation, PIPEs and the controversial world of reverse mergers and penny stocks. His work has appeared in newspapers and magazines throughout California as well as on PBS, “60 Minutes,” ABC News and CNBC. Meagher has also written video scripts and produced national events for a non-profit educational organization.
Recent Articles By The Author
Why Rupert Murdoch Will Survive the Fox scandal
Sexual harassment allegations at Fox News have hurt the value of Twenty-First Century Fox, but its governance keeps the Murdoch family that controls it beyond the reach of investor outrage.
Another Way to Invest With the Smart Money: SPACs
Once a shaky alternative to conventional IPOs, special-purpose acquisition companies let the public in on private equity bets.
Reverse Mergers Losing Out to Lower-Cost Offerings
Regulation A+ and self-underwritten offerings may be the vehicles of choice for companies that can't afford a traditional IPO.
How Martin Shkreli Defended His Biotech Shorting Scheme
In this interview with The Deal's Bill Meagher, first posted on Jan. 17, 2013, Shkreli defends his drug business and his shorting strategy.
SEC Takes On Ironridge Global Partners Over Deals Based on Buying Microcap Bills From Creditors
Ironridge is one of about a half-dozen companies that are following a strategy to invest in microcap firms.